Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 70101-70150 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05921305
Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD
PHASE3Recruiting
218 participants
Started: Aug 3, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor2 locations
NCT06131814
Effects of Integrated And Isolated Resisted Exercise on Strength, Power And Endurance
NARecruiting
54 participants
Started: Aug 3, 2023 · Completed: Jan 3, 2024
2 conditions1 sponsor1 location
NCT05698147
Selinexor in Combination With MTX+Ritu to Treat R/R CNSL
PHASE1/PHASE2Recruiting
30 participants
Started: Aug 3, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors5 locations
NCT05867420
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
PHASE1Recruiting
104 participants
Started: Aug 3, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT06038396
A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
48 participants
Started: Aug 3, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor18 locations
NCT05984238
A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2)
NARecruiting
32 participants
Started: Aug 3, 2023 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05936853
The EPigenetic Consequences in Children of Intravenous vs Volatile Anaesthesia for Surgery (EPIVA)
NAActive, not recruiting
16 participants
Started: Aug 3, 2023 · Completed: Sep 30, 2026
4 conditions2 sponsors1 location
NCT05793320
Carpal Tunnel Release With Risk Factors for Amyloidosis
NARecruiting
250 participants
Started: Aug 3, 2023 · Completed: Dec 3, 2024
1 condition1 sponsor1 location
NCT05986916
Accurate Point of Care Liver Disease Diagnostics
N/AActive, not recruiting
50 participants
Started: Aug 3, 2023 · Completed: Nov 30, 2025
2 conditions4 sponsors1 location
NCT06186128
Universal Basic Income and Structural Racism in the US South: HIV Care
NARecruiting
80 participants
Started: Aug 3, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT03861676
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
EARLY_PHASE1Recruiting
20 participants
Started: Aug 3, 2023 · Completed: Dec 31, 2033
1 condition3 sponsors1 location
NCT05797740
Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)
N/AActive, not recruiting
367 participants
Started: Aug 3, 2023 · Completed: Jan 31, 2029
1 condition1 sponsor30 locations
NCT06595732
Contin-RUN Study: Urinary Incontinence in Female Runners
NARecruiting
174 participants
Started: Aug 3, 2023 · Completed: Jul 20, 2025
1 condition1 sponsor1 location
NCT05973916
Comprehensive Intervention to Improve Environmental Disinfection
NARecruiting
1,400 participants
Started: Aug 3, 2023 · Completed: Aug 3, 2025
1 condition1 sponsor1 location
NCT05891509
DTI-guided Minimally Invasive Hematoma Evacuation for Intracerebral Hemorrhage
NARecruiting
100 participants
Started: Aug 3, 2023 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT06131736
Effects of High Intensity Interval Training and Cluster Training on Speed, Explosive Strength and Functional Performance
NARecruiting
54 participants
Started: Aug 3, 2023 · Completed: Jan 3, 2024
3 conditions1 sponsor1 location
NCT06178601
A Study of RC48-ADC Combined With Cadonilimab(AK104)in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma
PHASE2Recruiting
36 participants
Started: Aug 3, 2023 · Completed: Apr 1, 2026
1 condition2 sponsors2 locations
NCT06509360
How do You Feelee? Emotion-based Smartphone App in the Forensic Outpatient Setting
NARecruiting
24 participants
Started: Aug 3, 2023 · Completed: Dec 31, 2024
2 conditions4 sponsors2 locations
NCT06249997
An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS
PHASE3Recruiting
3 participants
Started: Aug 3, 2023 · Completed: Mar 31, 2025
1 condition4 sponsors2 locations
NCT06487130
Virtual perI-/Menopause Registry of AusTrALia
N/ARecruiting
10,000 participants
Started: Aug 3, 2023 · Completed: Aug 31, 2073
20 conditions1 sponsor1 location
NCT05887375
Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery
PHASE4Enrolling by invitation
118 participants
Started: Aug 3, 2023 · Completed: Jun 30, 2026
3 conditions2 sponsors1 location
NCT05963347
Go-CHOP as the Frontline Therapy for PTCL
PHASE2Recruiting
45 participants
Started: Aug 3, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05899179
Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above
PHASE3Recruiting
780 participants
Started: Aug 3, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor8 locations
NCT06011525
Prevention of Alopecia in Patients With Localised Breast Cancer
NARecruiting
196 participants
Started: Aug 3, 2023 · Completed: Sep 3, 2026
1 condition1 sponsor3 locations
NCT05583708
Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
PHASE2Recruiting
18 participants
Started: Aug 3, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor3 locations
NCT04629820
PROductivity Study of Presbyopia Elimination in Rural-dwellers II
NARecruiting
800 participants
Started: Aug 3, 2023 · Completed: Jun 30, 2024
1 condition6 sponsors1 location
NCT06100341
ImGTS for Patients With Cerebral Palsy and With Mobility Limitations (Phase 2)
NARecruiting
30 participants
Started: Aug 2, 2023 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT05797246
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
PHASE2Recruiting
50 participants
Started: Aug 2, 2023 · Completed: Nov 2, 2026
15 conditions1 sponsor1 location
NCT05986097
The Breakfast Study
PHASE1/PHASE2Active, not recruiting
120 participants
Started: Aug 2, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06002126
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
NAActive, not recruiting
1,002 participants
Started: Aug 2, 2023 · Completed: Mar 31, 2027
4 conditions7 sponsors2 locations
NCT05535764
Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis
PHASE1Recruiting
18 participants
Started: Aug 2, 2023 · Completed: Oct 30, 2027
1 condition1 sponsor1 location
NCT06222190
Lung_Cancer_adaptive - Ethos
N/ARecruiting
30 participants
Started: Aug 2, 2023 · Completed: Feb 28, 2025
1 condition1 sponsor1 location
NCT05915923
Effect of Transcranial Magnetic Stimulation on Dynamic Cerebral Autoregulation in Healthy Adults
NARecruiting
90 participants
Started: Aug 2, 2023 · Completed: Apr 20, 2024
1 condition1 sponsor1 location
NCT05992909
Prophylactic Lymphovenous Bypass Procedure Following Inguinal Lymphadenectomy: A Prospective Observational Study
N/ARecruiting
20 participants
Started: Aug 2, 2023 · Completed: Aug 1, 2027
1 condition1 sponsor1 location
NCT06544720
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
PHASE1Recruiting
18 participants
Started: Aug 2, 2023 · Completed: Dec 31, 2026
8 conditions1 sponsor1 location
NCT07003191
Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes
N/AActive, not recruiting
2,600 participants
Started: Aug 2, 2023 · Completed: Dec 31, 2025
1 condition50 sponsors1 location
NCT05969041
Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
PHASE1Recruiting
48 participants
Started: Aug 2, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor6 locations
NCT05972655
Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer
PHASE2Recruiting
32 participants
Started: Aug 2, 2023 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT06575205
Patient Education Video to Reduce OTC NSAIDs
NAActive, not recruiting
1,452 participants
Started: Aug 2, 2023 · Completed: Mar 15, 2025
3 conditions2 sponsors1 location
NCT05975333
Writing Intervention With Adolescents and Young Adults With Cancer
NARecruiting
26 participants
Started: Aug 2, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT07111858
Pavlik Harness Treatment vs Monitoring for Treatment of Developmental Dysplasia of the Hip (DDH) in Babies Diagnosed With Graf Type 2 Hips
NARecruiting
70 participants
Started: Aug 2, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05709028
Fosfomycin Versus Standard of Care in Children With Antibiotic-resistant Urinary Tract Infections
PHASE3Recruiting
300 participants
Started: Aug 2, 2023 · Completed: Aug 31, 2027
1 condition1 sponsor5 locations
NCT05894070
The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer
N/ARecruiting
100 participants
Started: Aug 2, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor2 locations
NCT06501859
Rehabilitation with the Shoulder Pacemaker
NAEnrolling by invitation
100 participants
Started: Aug 2, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05582551
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
NARecruiting
146 participants
Started: Aug 2, 2023 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05985148
A Study of Stereotactic Radiosurgery (SRS) to Treat Pain in the Chest and/or Stomach Wall
PHASE1Recruiting
18 participants
Started: Aug 2, 2023 · Completed: Aug 31, 2028
2 conditions2 sponsors7 locations
NCT05910957
Multi-Omic, Clinomic and Digitomic Attributes of Major Depression for Integrative Analytics
N/AEnrolling by invitation
40 participants
Started: Aug 2, 2023 · Completed: Dec 6, 2026
2 conditions2 sponsors1 location
NCT06032026
Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15
EARLY_PHASE1Recruiting
70 participants
Started: Aug 2, 2023 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT06145776
The Role of EEG in Identifying Cognitive Changes in Parkinson's Disease
NARecruiting
36 participants
Started: Aug 2, 2023 · Completed: Apr 30, 2024
3 conditions1 sponsor2 locations
NCT05818553
A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)
PHASE2/PHASE3Recruiting
100 participants
Started: Aug 2, 2023 · Completed: Mar 1, 2027
2 conditions1 sponsor5 locations